Showing results (281-290 of 310) with videos related to

Sort By:
Pageof 31
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|March 7, 2015
[Performance comparison of material tests for cadmium and lead in food contact plastics]Motoh Mutsuga, Tomoyuki Abe, Yutaka Abe, et al.
Artificial Organs|March 19, 2020
Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapyToshiya Okahisa, Masahiro Sogabe, Tadahiko Nakagawa, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|July 10, 2015
[Interlaboratory Study on Zinc Test for Food-Contact Rubber Products]Hiroshi Shibata, Motoh Mutsuga, Yutaka Abe, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|May 1, 2015
[Interlaboratory study on migration test of antimony and germanium for food-contact polyethylene terephthalate]Ryo Murakami, Motoh Mutsuga, Takashi Abe, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|June 1, 2022
[Validation Study on Migration Test for Plastic Food Utensils, Containers, and Packaging]Asako Ozaki, Motoh Mutsuga, Eri Kishi, et al.
Cancer Medicine|May 26, 2019
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 21, 2011
Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosisAkiyuki Tomiyasu, Masayuki Nakamura, Mio Ichiba, et al.
Oncology|February 26, 2020
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Infectious Diseases and Therapy|November 3, 2020
Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter StudyToshifumi Tada, Takashi Kumada, Hiroaki Okushin, et al.
Oncology|July 16, 2019
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
Pageof 31